Cargando…

Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies

Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Liaqat, Aamir, Noor, Hussain, Musaddique, Asif, Muhammad, Chauhdary, Zunera, Manzoor, Faiza, Siddique, Rida, Riaz, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536891/ https://www.ncbi.nlm.nih.gov/pubmed/36212951 http://dx.doi.org/10.1155/2022/5143653

Ejemplares similares

Effects of Momordica charantia (Bitter Melon) on Ischemic Diabetic Myocardium
por: Czompa, Attila, et al.
Publicado: (2017)

A case of atrial fibrillation due to Momordica charantia (bitter melon)
por: Erden, Ismail, et al.
Publicado: (2010)

Diverse roles of bitter melon (Momordica charantia) in prevention of oral cancer
por: Sur, Subhayan, et al.
Publicado: (2021)

Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica charantia)
por: Cao, Heping, et al.
Publicado: (2014)

Identification and Characterization of Phenylpropanoid Biosynthetic Genes and Their Accumulation in Bitter Melon (Momordica charantia)
por: Cuong, Do Manh, et al.
Publicado: (2018)

Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
por: Sur, Subhayan, et al.
Publicado: (2020)

Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment
por: , Mahwish, et al.
Publicado: (2021)

Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice
por: Mohammadmoradi, Shayan, et al.
Publicado: (2020)

Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
por: Nerurkar, Pratibha V, et al.
Publicado: (2011)

Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
por: Nerurkar, Pratibha V, et al.
Publicado: (2010)

The Butanol Fraction of Bitter Melon (Momordica charantia) Scavenges Free Radicals and Attenuates Oxidative Stress
por: Kim, Hyun Young, et al.
Publicado: (2013)

Investigation of Biological Activities of Wild Bitter Melon (Momordica charantia Linn. Var. Abbreviata Ser.)
por: Pham, Thi My Hanh, et al.
Publicado: (2019)

Suppression of Inflammatory Cytokines Expression with Bitter Melon (Momordica Charantia) in TNBS-instigated Ulcerative Colitis
por: Semiz, Asli, et al.
Publicado: (2020)

Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products
por: AKYÜZ, Esin, et al.
Publicado: (2020)

Influence of Total Anthocyanins from Bitter Melon (Momordica charantia Linn.) as Antidiabetic and Radical Scavenging Agents
por: Güdr, Aytaç
Publicado: (2016)

Effects of Fagonia indica on Letrozole-Induced Polycystic Ovarian Syndrome (PCOS) in Young Adult Female Rats
por: Younas, Anam, et al.
Publicado: (2022)

Comparative Pre-clinical Efficacy of Chinese and Indian Cultivars of Bitter Melon (Momordica charantia) against Pancreatic Cancer
por: Kandhari, Kushal, et al.
Publicado: (2021)

Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia)
por: Mahwish, et al.
Publicado: (2017)

Bitter Melon (Momordica charantia L.) Rootstock Improves the Heat Tolerance of Cucumber by Regulating Photosynthetic and Antioxidant Defense Pathways
por: Tao, Mei-Qi, et al.
Publicado: (2020)

Biochemical Stress Markers, Antioxidants, and Infectious Wound-Healing Potential of UV Irradiation and Salt Stress Effects on the Pre-Treated Seed of Bitter Melon (Momordica charantia L.)
por: Abbas, Mazhar, et al.
Publicado: (2021)

An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia
por: Poolperm, Sutthaya, et al.
Publicado: (2017)

Analysis of the Complete Mitochondrial Genome of the Bitter Gourd (Momordica charantia)
por: Niu, Yu, et al.
Publicado: (2023)

Pharmacological Potential of the Standardized Methanolic Extract of Prunus armeniaca L. in the Haloperidol-Induced Parkinsonism Rat Model
por: Saleem, Uzma, et al.
Publicado: (2022)

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2011)

Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study
por: Saad, Dalia Yossri, et al.
Publicado: (2017)

Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model
por: Reed, Dominique, et al.
Publicado: (2021)

Antioxidative and Antimelanogenesis Effect of Momordica charantia Methanol Extract
por: Park, Sang Hee, et al.
Publicado: (2019)

Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon)
por: Hazarika, Ridip, et al.
Publicado: (2012)

Correction: strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management
por: Snee, Laura S, et al.
Publicado: (2014)

Momordica charantia (Bitter Melon) Reduces Obesity-Associated Macrophage and Mast Cell Infiltration as well as Inflammatory Cytokine Expression in Adipose Tissues
por: Bao, Bin, et al.
Publicado: (2013)

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation
por: Zeng, Yanmei, et al.
Publicado: (2018)

Momordica charantia (bitter melon) efficacy and safety on glucose metabolism in Korean prediabetes participants: a 12-week, randomized clinical study
por: Kim, Bukyung, et al.
Publicado: (2022)

Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade
por: Yung, Mingo M. H., et al.
Publicado: (2015)

Effects of drying conditions in low‐temperature microwave‐assisted drying on bioactive compounds and antioxidant activity of dehydrated bitter melon (Momordica charantia L.)
por: Nguyen, Thi‐Van‐Linh, et al.
Publicado: (2020)

Potential Biomarkers of Peripheral and Central Fatigue in High-Intensity Trained Athletes at High-Temperature: A Pilot Study with Momordica charantia (Bitter Melon)
por: Kwak, Jae-Jun, et al.
Publicado: (2020)

Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis
por: Matsumura, Hideo, et al.
Publicado: (2014)

Genome-Wide Analysis of Simple Sequence Repeats in Bitter Gourd (Momordica charantia)
por: Cui, Junjie, et al.
Publicado: (2017)

Antioxidant, cell-protective, and anti-melanogenic activities of leaf extracts from wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) cultivars
por: Tsai, Tsung-Hsien, et al.
Publicado: (2014)

Telomere-to-telomere genome assembly of bitter melon (Momordica charantia L. var. abbreviata Ser.) reveals fruit development, composition and ripening genetic characteristics
por: Fu, Anzhen, et al.
Publicado: (2022)

Nanobiotechnology can boost crop production and quality: first evidence from increased plant biomass, fruit yield and phytomedicine content in bitter melon (Momordica charantia)
por: Kole, Chittaranjan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ihh1b88n8u0m990mrfulfe1ke6